English  |  正體中文  |  简体中文  |  总笔数 :2851816  
造访人次 :  44939539    在线人数 :  1289
教育部委托研究计画      计画执行:国立台湾大学图书馆
 		 
搜寻范围 进阶搜寻
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR
计画说明

浏览
典藏机构
作者
题名
日期
统计图表
机构即时统计
学术趋势

消息
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

著作权
出版社及期刊政策查询
TAIR著作权会议记录

相关连结
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
台湾机构典藏 TAIR >  依作者浏览

"tseng t c"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 231-280 / 534 (共11页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-09-04T05:16:30Z Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients Yeo Y.H.; Tseng T.-C.; Hosaka T.; Cunningham C.; Fung J.Y.Y.; Ho H.J.; Kwak M.-S.; Trinh H.N.; Ungtrakul T.; Yu M.-L.; Kobayashi M.; Le A.K.; Henry L.; Li J.; Zhang J.; Sriprayoon T.; Jeong D.; Tanwandee T.; Gane E.; Cheung R.C.; Wu C.-Y.; Lok A.S.; Lee H.-S.; Suzuki F.; Yuen M.-F.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H.
臺大學術典藏 2021-09-04T05:16:29Z Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan Su H.-J.; JIA-HORNG KAO; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; Liu C.-J.
臺大學術典藏 2021-09-04T05:16:27Z High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:23Z Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection—authors' reply Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:22Z APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients JIA-HORNG KAO; Jeng W.-J.; Ning Q.; Su T.-H.; Tseng T.-C.; Ueno Y.; Yuen M.-F.
臺大學術典藏 2021-09-04T05:16:21Z Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis Su T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Liu C.-H.; Yang H.-C.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:20Z Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients Liu M.; Tseng T.-C.; Jun D.W.; Yeh M.-L.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung M.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H.
臺大學術典藏 2021-09-04T05:16:20Z One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment Tseng T.-C.; Choi J.; Nguyen M.H.; Peng C.-Y.; Siakavellas S.; Papatheodoridis G.; Wang C.-C.; Lim Y.-S.; Lai H.-C.; Trinh H.N.; Wong C.; Wong C.; Zhang J.; Li J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:18Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏 2021-08-20T07:38:56Z Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy Liu C.-H.; Sun H.-Y.; SZU-MIN HSIEH; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-08-20T07:10:54Z Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy Liu C.-H.; HSIN-YUN SUN; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-12T02:44:50Z Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Tseng T.-C; | Liu C.-J; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Chen C.-L; | Fang-Tzu Kuo S; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:50Z High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Tseng T.-C; | Liu C.-J; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Chen C.-L; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:49Z Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation Tseng T.-C; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Wang C.-C; | Chen C.-L; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:48Z Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads Tseng T.-C; | Liu C.-J; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Chen C.-L; | Hsu C.-A; | Fang-Tzu Kuo S; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:47Z Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers Tseng T.-C; | Liu C.-J; | Chen C.-L; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Yang W.-T; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:46Z Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters Tseng T.-C; | Liu C.-J; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:43Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C; | Liu C.-J; | Chen C.-L; | Yang W.-T; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:41Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C; | Liu C.-J; | HUNG-CHIH YANG; | Chen C.-L; | Yang W.-T; | Tsai C.-S; | Kuo S.F.-T; | Verbree F.C; | Su T.-H; | Wang C.-C; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:37Z More viral mutants, less HBsAg clearance? One size may not fit all Tseng T.-C; | HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:36Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:32Z Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:25Z High Level of Hepatitis B Core�VRelated Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C; | Liu C.-J; | Hsu C.-Y; | Hong C.-M; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Huang Y.-T; | Fang-Tzu Kuo S; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:24Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C; | Liu C.-J; | Chang C.T; | Su T.-H; | Yang W.-T; | Tsai C.-H; | Chen C.-L; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:24Z Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy Tseng T.-C; | Peng C.-Y; | Hsu Y.-C; | Su T.-H; | Wang C.-C; | Liu C.-J; | HUNG-CHIH YANG; | Yang W.-T; | Lin C.-H; | Yu M.-L; | Lai H.-C; | Tanaka Y; | Nguyen M.H; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:19Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C; | Liu C.-J; | Yang W.-T; | Hsu C.-Y; | Hong C.-M; | Su T.-H; | Tsai C.-H; | Chen C.-L; | HUNG-CHIH YANG; | Liu C.-H; | Chen H.-H; | Chen P.-J; | Kao J.-H.
臺大學術典藏 2021-07-03T03:35:08Z Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan Tseng T.-C.; Liu C.-J.; PEI-JER CHEN; Lai M.-Y.; Lin C.-L.; Kao J.-K.; Chen D.-S.
臺大學術典藏 2021-07-03T03:35:00Z A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients Tseng T.-C.; Liu C.-J.; Wang C.-C.; PEI-JER CHEN; Lai M.-Y.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:58Z Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial Liu C.-H.; Liu C.-J.; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:56Z Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels Tseng T.-C.; Liu C.-J.; Wang C.-C.; PEI-JER CHEN; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:54Z Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C Hsieh T.-H.; Tseng T.-C.; Liu C.-J.; Lai M.-Y.; PEI-JER CHEN; Hsieh H.-L.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:51Z Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy Tseng T.-C.; Liu C.-J.; Hsieh S.-C.; PEI-JER CHEN; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:46Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B Su T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; PEI-JER CHEN; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:46Z Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:38Z Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:35Z Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; Liu C.-J.; Lai M.-Y.; PEI-JER CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:35Z Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C Liu C.-J.; Cheng H.-R.; Chen C.-L.; Chen T.-C.; Tseng T.-C.; Wang Z.-L.; PEI-JER CHEN; Liu C.-H.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:32Z Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters Tseng T.-C.; Liu C.-J.; Chen C.-L.; Wang C.-C.; Su T.-H.; Kuo S.F.-T.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:32Z High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:31Z Impact of hepatitis B virus infection on metabolic profiles and modifying factors Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:30Z Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission Lin C.-L.; Tseng T.-C.; Su T.-H.; Liu C.-J.; PEI-JER CHEN; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:30Z Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B Pan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; Kao J.-H.; Tseng T.-C.; Liu C.-H.; PEI-JER CHEN; Liu C.-J.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:28Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:28Z Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:27Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:25Z Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:21Z Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:20Z Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:17Z Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection Su T.-H.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; PEI-JER CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:15Z Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.

显示项目 231-280 / 534 (共11页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team